ConductScience.org, home

Paper895764

Inefficacy of immediate node dissection in stage 1 melanoma of the limbs.

Veronesi U and 19 others. N Engl J Med, 1977. Cited by 571 papers, by iCite.

Cite this record

ConductScience Library. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. Papers, record 895764. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/895764

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inefficacy of immediate node dissection in stage 1 melanoma of the limbs.
PubMed
Journal
N Engl J Med
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
571
iCite
Relative citation ratio, by iCite
18.9
iCite
Revised in PubMed
2007-11-15
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Veronesi UU
2Adamus JJ
3Bandiera DCD C
4Brennhovd IOI O
5Caceres EE
6Cascinelli NN
7Claudio FF
8Ikonopisov RLR L
9Javorskj VVV V
10Kirov SS
11Kulakowski AA
12Lacoub JJ
13Lejeune FF
14Mechl ZZ
15Morabito AA
16Rodé II
17Sergeev SS
18van Slooten EE
19Szcygiel KK
20Trapeznikov NNN N

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ExtremitiesMajor topic
Lymph Node ExcisionMajor topic
MelanomaMajor topic
Skin NeoplasmsMajor topic
Aged
Evaluation Studies as Topic
Female
Humans
Lymphatic Metastasis
Male
Prognosis
Prospective Studies
Sex Factors
World Health Organization

Source PubMed

Download CSV of topics

Cited by82

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 571 citations.

PMIDTitleJournalYearIn PapersSource
42104033Perspective Editorial: Assessment of Survival Benefit from Sentinel Node Biopsy for Melanoma: A Systematic Review and Meta-analysis.Ann Surg Oncol2026https://conductscience.org/library/papers/42104033PubMed
40883533Melanoma Great Debate: Targeted Versus Complete Nodal Dissection Following Neoadjuvant Therapy for Melanoma: Is it Time to Push Forward or Hold Off on Continued De-Escalation of Surgery?Ann Surg Oncol2025https://conductscience.org/library/papers/40883533PubMed
40717884Validity of Intraoperative Imprint Cytology and Frozen Section for Sentinel Lymph Node Assessment in Breast Cancer: A Single-Centre Experience.Cureus2025https://conductscience.org/library/papers/40717884PubMed
40338298[Value of surgery for malignant melanoma in the context of current adjuvant and neoadjuvant treatment concepts].Dermatologie (Heidelb)2025https://conductscience.org/library/papers/40338298PubMed
39550033Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.Ann Oncol2025https://conductscience.org/library/papers/39550033PubMed
38842606Management of Localized Melanoma in the Anti-PD-1 Era.Curr Oncol Rep2024https://conductscience.org/library/papers/38842606PubMed
35033317Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies.Curr Probl Surg2022https://conductscience.org/library/papers/35033317PubMed
31857858Evolving management of positive regional lymph nodes in melanoma: Past, present and future directions.Oncol Rev2019https://conductscience.org/library/papers/31857858PubMed
30548543Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers.J Surg Oncol2019https://conductscience.org/library/papers/30548543PubMed
30481384Current management of regional lymph nodes in patients with melanoma.J Surg Oncol2019https://conductscience.org/library/papers/30481384PubMed
30232648Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma.Curr Treat Options Oncol2018https://conductscience.org/library/papers/30232648PubMed
30190874Lymph nodes and the melanoma surgeon: re-defining a long-term relationship.Melanoma Manag2016https://conductscience.org/library/papers/30190874PubMed
29777421Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials.Clin Exp Metastasis2018https://conductscience.org/library/papers/29777421PubMed
29492467Completion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma.Laryngoscope Investig Otolaryngol2018https://conductscience.org/library/papers/29492467PubMed
28690674The Veronesi quadrantectomy: an historical overview.Ecancermedicalscience2017https://conductscience.org/library/papers/28690674PubMed
27051803Combined dabrafenib and trametinib therapy in metastatic melanoma and organ transplantation: Case report and review of the literature.JAAD Case Rep2015https://conductscience.org/library/papers/27051803PubMed
26790922Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial.Lancet Oncol2016https://conductscience.org/library/papers/26790922PubMed
26663853Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticle.Wiley Interdiscip Rev Nanomed Nanobiotechnol2016https://conductscience.org/library/papers/26663853PubMed
26098776Lymphatic dysfunction attenuates tumor immunity through impaired antigen presentation.Oncotarget2015https://conductscience.org/library/papers/26098776PubMed
25311346MSLT-I-response of clinical trial investigators.Nat Rev Clin Oncol2014https://conductscience.org/library/papers/25311346PubMed

See all 82 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/895764

GET https://conductscience.org/api/papers/v1/895764/cited_by?page=2